acute myeloid leukemia

(redirected from acute myelogenous leukemia)
Also found in: Thesaurus, Medical, Financial, Acronyms, Encyclopedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.acute myeloid leukemia - acute leukemia characterized by proliferation of granular leukocytesacute myeloid leukemia - acute leukemia characterized by proliferation of granular leukocytes; most common in adolescents and young adults
acute leukemia - rapidly progressing leukemia
granulocytic leukemia, myelocytic leukemia - a malignant neoplasm of blood-forming tissues; marked by proliferation of myelocytes and their presence in the blood
References in periodicals archive ?
The bone marrow aspirate was hypercellular, with 89% blasts compatible with acute myelogenous leukemia (Figure 2).
Kelly's exposure to these solvents and chemicals was a legal cause of his developing acute myelogenous leukemia and other blood disorders and diseases and other injuries and diseases.
Knight was diagnosed April 7 with acute myelogenous leukemia, which develops when there is a defect in bone marrow.
The annualized rate for the development of treatment-related myelodysplasia or acute myelogenous leukemia is less than 1 percent of patients and can occur at 8 to 34 months after treatment.
Two people developed acute myelogenous leukemia, a higher than normal incidence of this type of cancer.
And those differences mean "you can predict outcome not just in blood cancers but in brain tumors, neuroblastoma, acute myelogenous leukemia, ovarian cancer, and prostate cancer," he adds.
In an April 2001 report, the IOM said there was limited or suggestive" evidence that a parent's exposure to Agent Orange during the Vietnam War may read to a child contracting acute myelogenous leukemia.
IOM's claim last April (June/July 2001 Washington Wire) was based on three tests, one of which showed higher than expected rates of acute myelogenous leukemia in the children of Australian Vietnam vets.
In adolescents, ALL is the most common form of leukemia, but by age 29, acute myelogenous leukemia predominates.
Mandalam will provide an overview of Cellerant's cancer stem cell discovery approach and new data on its therapeutic antibodies demonstrating activity against acute myelogenous leukemia (AML) cancer stem cells.
Based on leukemia type the market is categorized into chronic leukemia, acute leukemia, chronic myeloid leukemia, acute myeloid leukemia, chronic myelogenous leukemia, acute myelogenous leukemia, chronic lymphatic leukemia, and acute lymphatic leukemia.

Full browser ?